Julia M Unglaub

3PUBLICATIONS
59CO-AUTHORS
Haematological tumoursGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|Sep 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML.

Julia M Unglaub, Richard F Schlenk, Jan Moritz Middeke

|Mar 09, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.

Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders

Pageof 1

Frequent Collaborators

3 joint publications

Christoph Röllig

2 joint publications

Carsten Müller-Tidow

2 joint publications

Martin Bornhäuser

2 joint publications

Tim Sauer